Skip to Content

Month: June 2021

Two House committees have launched an investigation into the approval and pricing of the Alzheimer's disease drug aducanumab

US lawmakers launch investigation into FDA approval and price of new Alzheimer’s drug

By Jacqueline Howard, CNN Two House committees have launched an investigation into the approval and pricing of the Alzheimer’s disease drug aducanumab, made by the company Biogen and sold under the brand name Aduhelm. The US Food and Drug Administration approved the drug earlier this month under its “accelerated approval” program, although an FDA advisory

Continue Reading

Garland: DOJ will change its regulations on seeking journalists’ records to make policy more lasting

By Katelyn Polantz and Christina Carrega, CNN Attorney General Merrick Garland said Tuesday that the Justice Department has informed news industry leaders it will change its regulations around seeking records from journalists, in what appears to be a win for media outlets. News organizations have pushed for lasting change from the department to shut down

Continue Reading
A banner announcing the National Security Law in Hong Kong's Admiralty district on August 14

One year after Hong Kong’s national security law, residents feel Beijing’s tightening grip

By Jessie Yeung, CNN It was approaching midnight on June 30, 2020, when news broke that Beijing had promulgated a national security law in Hong Kong, effective immediately. Since China’s rubber-stamp parliament revealed its plans for such legislation the month before, Hong Kongers had been nervously awaiting the details of a law that would reshape

Continue Reading

Singapore wants to stop counting Covid cases. Its roadmap could be a model for other countries

By Helen Regan, CNN As countries around the Asia-Pacific region tighten restrictions once again to curb potential breakouts of the Delta coronavirus variant, Singapore has laid out a new vision for life to return to normal. The roadmap, proposed by three members of Singapore’s Covid-19 task force, would scrap lockdowns and mass contact tracing and

Continue Reading

US lawmakers launch investigation into FDA approval and price of new Alzheimer’s drug

By Jacqueline Howard, CNN Two House committees have launched an investigation into the approval and pricing of the Alzheimer’s disease drug aducanumab, made by the company Biogen and sold under the brand name Aduhelm. The US Food and Drug Administration approved the drug earlier this month under its “accelerated approval” program, although an FDA advisory

Continue Reading
Skip to content